{"transactions":[{"id":741781,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:41:11.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-267732","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000119312526267732/ownership.xml","form_type":"4"}},{"id":741782,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:26.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001478916-26-000009","document":"form4-06112026_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000147891626000009/form4-06112026_040611.xml","form_type":"4"}},{"id":741780,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:23.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001579826-26-000002","document":"form4-06112026_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000157982626000002/form4-06112026_040609.xml","form_type":"4"}},{"id":741778,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:20.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001754129-26-000006","document":"form4-06112026_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000175412926000006/form4-06112026_040607.xml","form_type":"4"}},{"id":741779,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:19.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001559570-26-000008","document":"form4-06112026_040613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000155957026000008/form4-06112026_040613.xml","form_type":"4"}},{"id":741777,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:17.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001751873-26-000002","document":"form4-06112026_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000175187326000002/form4-06112026_040606.xml","form_type":"4"}},{"id":822947,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-01T20:17:20.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over 12 months following March 31, 2026."}],"balance_after":7500,"derivative":{"exercise_price":10.64,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001559570-26-000006","document":"form4-04012026_080415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000155957026000006/form4-04012026_080415.xml","form_type":"4"}},{"id":822946,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39301,"kind":"person","name":"Shapiro David","position":1,"cik":"0001559570","reported_name":"Shapiro David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-01T20:17:20.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over 36 months following March 31, 2026."}],"balance_after":60000,"derivative":{"exercise_price":10.64,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001559570-26-000006","document":"form4-04012026_080415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000155957026000006/form4-04012026_080415.xml","form_type":"4"}},{"id":951754,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70335,"kind":"person","name":"Storgard Chris","position":1,"cik":"0001674703","reported_name":"Storgard Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:14:17.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":250000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001674703-26-000002","document":"form4-01052026_090112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000167470326000002/form4-01052026_090112.xml","form_type":"4"}},{"id":951753,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70334,"kind":"person","name":"Jeffries Sean","position":1,"cik":"0001848377","reported_name":"Jeffries Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:13:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":375000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001848377-26-000002","document":"form4-01052026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000184837726000002/form4-01052026_090157.xml","form_type":"4"}},{"id":951752,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70333,"kind":"person","name":"Burgess Julie","position":1,"cik":"0001883722","reported_name":"Burgess Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:11:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":150000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001883722-26-000002","document":"form4-01052026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000188372226000002/form4-01052026_090130.xml","form_type":"4"}},{"id":951751,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:10:23.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025."}],"balance_after":45000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001754129-26-000002","document":"form4-01052026_090117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000175412926000002/form4-01052026_090117.xml","form_type":"4"}},{"id":951750,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:08:50.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":750000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001580787-26-000002","document":"form4-01052026_090147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000158078726000002/form4-01052026_090147.xml","form_type":"4"}},{"id":972712,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2025-12-11T21:30:27.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001580787-25-000006","document":"form4-12112025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000158078725000006/form4-12112025_041203.xml","form_type":"4"}},{"id":972711,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2025-12-11T21:30:27.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001580787-25-000006","document":"form4-12112025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000158078725000006/form4-12112025_041203.xml","form_type":"4"}},{"id":1044061,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-09-10T21:18:17.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over 12 months following September 9, 2025."}],"balance_after":15833,"derivative":{"exercise_price":6.64,"expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":15833},"source":{"system":"sec-edgar","filing":"0001415889-25-024109","document":"form4-09102025_090913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925024109/form4-09102025_090913.xml","form_type":"4"}},{"id":1044060,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-09-10T21:18:17.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025."}],"balance_after":30000,"derivative":{"exercise_price":6.64,"expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-024109","document":"form4-09102025_090913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925024109/form4-09102025_090913.xml","form_type":"4"}},{"id":1066589,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T20:15:08.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":217627,"price":5.25,"value":1142541.75,"ownership":{"direct":false,"nature":"By Logos Opportunities Fund II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP (\"LOF II\"). Logos Opportunities GP LLC (\"GP I\") is the general partner of LOF II. The Reporting Person is the Managing Member of GP I. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001415889-25-021842","document":"form4-08142025_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925021842/form4-08142025_040805.xml","form_type":"4"}},{"id":1066588,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T20:15:08.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":345000,"price":5.25,"value":1811250.0,"ownership":{"direct":false,"nature":"By Logos Global Master Fund LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Logos GP LLC (\"Fund GP\") is the general partner of Logos Global Master Fund LP (the \"Fund\"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2655000,"source":{"system":"sec-edgar","filing":"0001415889-25-021842","document":"form4-08142025_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925021842/form4-08142025_040805.xml","form_type":"4"}},{"id":1113584,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:48:21.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000950170-25-085506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000095017025085506/ownership.xml","form_type":"4"}},{"id":1113583,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:30:24.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-016957","document":"form4-06122025_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925016957/form4-06122025_040608.xml","form_type":"4"}},{"id":1113582,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:30:20.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-016959","document":"form4-06122025_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925016959/form4-06122025_040614.xml","form_type":"4"}},{"id":1113581,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:30:18.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-016956","document":"form4-06122025_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925016956/form4-06122025_040606.xml","form_type":"4"}},{"id":1113579,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:30:16.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-016958","document":"form4-06122025_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925016958/form4-06122025_040611.xml","form_type":"4"}},{"id":1113580,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:30:14.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-016955","document":"form4-06122025_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925016955/form4-06122025_040604.xml","form_type":"4"}},{"id":1135462,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70335,"kind":"person","name":"Storgard Chris","position":1,"cik":"0001674703","reported_name":"Storgard Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-23T20:26:36.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 25% of the shares will vest on April 16, 2026 and the balance of the shares will vest in equal monthly installments thereafter over the following 36 months."}],"balance_after":400000,"derivative":{"exercise_price":4.71,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001415889-25-014477","document":"form4-05232025_080531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925014477/form4-05232025_080531.xml","form_type":"4"}},{"id":1310880,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:00:35.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":25993,"derivative":{"exercise_price":6.17,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":25993},"source":{"system":"sec-edgar","filing":"0001415889-25-000880","document":"form4-01062025_070132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925000880/form4-01062025_070132.xml","form_type":"4"}},{"id":1310879,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70333,"kind":"person","name":"Burgess Julie","position":1,"cik":"0001883722","reported_name":"Burgess Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:00:33.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2026, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":135000,"derivative":{"exercise_price":6.17,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001415889-25-000879","document":"form4-01062025_070130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925000879/form4-01062025_070130.xml","form_type":"4"}},{"id":1310876,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:00:31.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2026, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":600000,"derivative":{"exercise_price":6.17,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001415889-25-000878","document":"form4-01062025_070127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925000878/form4-01062025_070127.xml","form_type":"4"}},{"id":1310878,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70334,"kind":"person","name":"Jeffries Sean","position":1,"cik":"0001848377","reported_name":"Jeffries Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:00:29.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2026, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":260000,"derivative":{"exercise_price":6.17,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001415889-25-000877","document":"form4-01062025_070125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925000877/form4-01062025_070125.xml","form_type":"4"}},{"id":1325477,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T23:30:05.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":3806,"price":6.27,"value":23863.62,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001415889-24-029913","document":"form4-12192024_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924029913/form4-12192024_061201.xml","form_type":"4"}},{"id":1436069,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:30:21.000Z","date":"2024-08-09","kind":"sale","planned":false,"acquired":false,"shares":814874,"price":4.25,"value":3463214.5,"ownership":{"direct":false,"nature":"By Logos SPV I LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP (\"LOF II\") and Logos SPV 1 LP (\"SPV 1\"). Logos Opportunities GP LLC (\"GP I\") is the general partner of LOF II. Logos Opportunities II GP LLC (\"GP II\") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-021086","document":"form4-08122024_080818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924021086/form4-08122024_080818.xml","form_type":"4"}},{"id":1477401,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:06:32.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000950170-24-074363","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000095017024074363/ownership.xml","form_type":"4"}},{"id":1477400,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:00:23.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-017241","document":"form4-06172024_050620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924017241/form4-06172024_050620.xml","form_type":"4"}},{"id":1477399,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:00:22.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-017239","document":"form4-06172024_050616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924017239/form4-06172024_050616.xml","form_type":"4"}},{"id":1477398,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:00:21.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-017240","document":"form4-06172024_050618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924017240/form4-06172024_050618.xml","form_type":"4"}},{"id":1477397,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:00:19.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-017238","document":"form4-06172024_050614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924017238/form4-06172024_050614.xml","form_type":"4"}},{"id":1477395,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:00:18.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-017237","document":"form4-06172024_050611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924017237/form4-06172024_050611.xml","form_type":"4"}},{"id":1561952,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T23:10:26.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":17809,"price":3.74,"value":66605.66,"ownership":{"direct":false,"nature":"By Schmid Family Trust U/A dated 8-15-17"},"balance_after":26965,"source":{"system":"sec-edgar","filing":"0001415889-24-009063","document":"form4-03252024_110321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924009063/form4-03252024_110321.xml","form_type":"4"}},{"id":1561951,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T23:10:26.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":9156,"price":3.6187,"value":33132.8172,"ownership":{"direct":false,"nature":"By Schmid Family Trust U/A dated 8-15-17"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.6187, and the range of prices were between $3.43 and $3.72.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the trust."}],"balance_after":9156,"source":{"system":"sec-edgar","filing":"0001415889-24-009063","document":"form4-03252024_110321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924009063/form4-03252024_110321.xml","form_type":"4"}},{"id":1561950,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T23:09:14.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":1300,"price":3.7429,"value":4865.77,"ownership":{"direct":true},"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001415889-24-009062","document":"form4-03252024_110307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924009062/form4-03252024_110307.xml","form_type":"4"}},{"id":1685598,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70333,"kind":"person","name":"Burgess Julie","position":1,"cik":"0001883722","reported_name":"Burgess Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T21:41:51.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":110000,"derivative":{"exercise_price":2.54,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-24-001042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919124001042/doc4.xml","form_type":"4"}},{"id":1685597,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70334,"kind":"person","name":"Jeffries Sean","position":1,"cik":"0001848377","reported_name":"Jeffries Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T21:40:29.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":350000,"derivative":{"exercise_price":2.54,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-24-001039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919124001039/doc4.xml","form_type":"4"}},{"id":1721924,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-06T00:00:43.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":69186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 25% of the shares will vest on November 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":69186,"derivative":{"exercise_price":2.51,"expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":69186},"source":{"system":"sec-edgar","filing":"0001209191-23-057552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123057552/doc4.xml","form_type":"4"}},{"id":1722008,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":107747,"kind":"person","name":"Ansari Aseem Z.","position":1,"cik":"0001849177","reported_name":"Ansari Aseem Z.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-05T18:57:52.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 25% of the shares will vest on October 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":100000,"derivative":{"exercise_price":2.51,"expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-057548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849177/000120919123057548/doc4.xml","form_type":"4"}},{"id":1770551,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-02T22:01:58.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":21000,"price":2.347,"value":49287.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased at a range of prices between $2.33 and $2.38.  Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":133024,"source":{"system":"sec-edgar","filing":"0001209191-23-051175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123051175/doc4.xml","form_type":"4"}},{"id":1787354,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T21:13:04.000Z","date":"2021-03-30","kind":"purchase","planned":false,"acquired":true,"shares":700000,"price":20,"value":14000000.0,"ownership":{"direct":false,"nature":"By Logos Global Master Fund LP"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being amended to correct the amount of securities beneficially owned by the Reporting Person.  This error resulted in the misreporting of the amount of securities beneficially owned by the Reporting Person on subsequent reports."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Logos GP LLC (\"Fund GP\") is the general partner of Logos Global Master Fund LP (the \"Fund\"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001209191-23-048441","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048441/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-01"}},{"id":1787353,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T21:13:04.000Z","date":"2021-03-30","kind":"exercise","planned":false,"acquired":true,"shares":814874,"ownership":{"direct":false,"nature":"By Logos SPV 1 LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being amended to correct the amount of securities beneficially owned by the Reporting Person.  This error resulted in the misreporting of the amount of securities beneficially owned by the Reporting Person on subsequent reports."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP (\"LOF II\") and Logos SPV 1 LP (\"SPV 1\"). Logos Opportunities GP LLC (\"GP I\") is the general partner of LOF II. Logos Opportunities II GP LLC (\"GP II\") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":814874,"source":{"system":"sec-edgar","filing":"0001209191-23-048441","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048441/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-01"}},{"id":1787352,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T21:13:04.000Z","date":"2021-03-30","kind":"exercise","planned":false,"acquired":true,"shares":1217627,"ownership":{"direct":false,"nature":"By Logos Opportunities Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being amended to correct the amount of securities beneficially owned by the Reporting Person.  This error resulted in the misreporting of the amount of securities beneficially owned by the Reporting Person on subsequent reports."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP (\"LOF II\") and Logos SPV 1 LP (\"SPV 1\"). Logos Opportunities GP LLC (\"GP I\") is the general partner of LOF II. Logos Opportunities II GP LLC (\"GP II\") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1217627,"source":{"system":"sec-edgar","filing":"0001209191-23-048441","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048441/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-01"}},{"id":1789346,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-05T21:33:07.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest as follows provided that the Company initiates a Phase 2a clinical trial for a product candidate for the treatment of FA: 25% of the shares subject to the option will vest one year following August 25, 2023, and thereafter the balance of the shares will vest in equal monthly installments over the following 36 months."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-23-048222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048222/doc4.xml","form_type":"4"}},{"id":1789345,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-05T21:33:07.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest as follows provided that an investigational new drug application for a product candidate for the treatment of Friedrich ataxia (\"FA\") submitted by the Issuer after September 1, 2023 receives clearance from the U.S. Food and Drug Administration: 25% of the shares subject to the option will vest one year following August 25, 2023, and thereafter the balance of the shares will vest in equal monthly installments over the following 36 months."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-23-048222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048222/doc4.xml","form_type":"4"}},{"id":1789344,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-05T21:33:07.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest one year following August 25, 2023, and thereafter the balance of the shares will vest in equal monthly installments over the following 36 months."}],"balance_after":1050000,"derivative":{"exercise_price":2.48,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001209191-23-048222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048222/doc4.xml","form_type":"4"}},{"id":1793133,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T22:06:59.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":2.3058,"value":27669.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.29 to $2.31, inclusive.  The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein."}],"balance_after":23806,"source":{"system":"sec-edgar","filing":"0001209191-23-047774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123047774/doc4.xml","form_type":"4"}},{"id":1793132,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T22:02:07.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":1960000,"price":2.44,"value":4782400.0,"ownership":{"direct":false,"nature":"By Logos Global Master Fund LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average purchase price for the transaction was $2.44.  The shares were purchased at a range of prices between $2.29 and $2.50, inclusive.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Logos GP LLC (\"Fund GP\") is the general partner of Logos Global Master Fund LP (the \"Fund\"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":3000000,"source":{"system":"sec-edgar","filing":"0001209191-23-047773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123047773/doc4.xml","form_type":"4"}},{"id":1793131,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T22:02:07.000Z","date":"2023-08-28","kind":"purchase","planned":false,"acquired":true,"shares":275000,"price":2.15,"value":591250.0,"ownership":{"direct":false,"nature":"By Logos Global Master Fund LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction was $2.15.  The shares were purchased at a range of prices between $2.11 and $2.1677, inclusive.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Logos GP LLC (\"Fund GP\") is the general partner of Logos Global Master Fund LP (the \"Fund\"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1040000,"source":{"system":"sec-edgar","filing":"0001209191-23-047773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123047773/doc4.xml","form_type":"4"}},{"id":1870165,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:48:21.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033847/doc4.xml","form_type":"4"}},{"id":1870164,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:47.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033787/doc4.xml","form_type":"4"}},{"id":1870162,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:46.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033784/doc4.xml","form_type":"4"}},{"id":1870163,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":112819,"kind":"person","name":"Xu Stella","position":1,"cik":"0001728741","reported_name":"Xu Stella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:44.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033785/doc4.xml","form_type":"4"}},{"id":1870160,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:38.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033782/doc4.xml","form_type":"4"}},{"id":1870161,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:35.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033781/doc4.xml","form_type":"4"}},{"id":1870156,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:24.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033778/doc4.xml","form_type":"4"}},{"id":2033212,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70333,"kind":"person","name":"Burgess Julie","position":1,"cik":"0001883722","reported_name":"Burgess Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T21:43:04.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":75000,"derivative":{"exercise_price":7.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-006927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123006927/doc4.xml","form_type":"4"}},{"id":2033211,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70334,"kind":"person","name":"Jeffries Sean","position":1,"cik":"0001848377","reported_name":"Jeffries Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T21:41:47.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":140000,"derivative":{"exercise_price":7.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-23-006921","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123006921/doc4.xml","form_type":"4"}},{"id":2033210,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T21:40:48.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":415000,"derivative":{"exercise_price":7.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001209191-23-006917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123006917/doc4.xml","form_type":"4"}},{"id":2033209,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T21:39:14.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":415000,"derivative":{"exercise_price":7.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001209191-23-006910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123006910/doc4.xml","form_type":"4"}},{"id":2078863,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-21T22:00:16.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":6300,"price":8.375,"value":52762.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.32 to $8.44, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein."}],"balance_after":132619,"source":{"system":"sec-edgar","filing":"0001209191-22-062349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062349/doc4.xml","form_type":"4"}},{"id":2078862,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-21T22:00:16.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":1150,"price":8.47,"value":9740.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,250 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (\"ESPP\") on November 15, 2021 and 1,220 shares acquired under the ESPP on May 13, 2022."}],"balance_after":126319,"source":{"system":"sec-edgar","filing":"0001209191-22-062349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062349/doc4.xml","form_type":"4"}},{"id":2079932,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:45:07.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":40000,"price":8.1358,"value":325432.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.86 to $8.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners I, LP (\"SR One Partners I\"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the SR One Fund I Aggregator securities in which the Reporting Person has no pecuniary interest, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes."}],"balance_after":6526476,"source":{"system":"sec-edgar","filing":"0001209191-22-062227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062227/doc4.xml","form_type":"4"}},{"id":2079931,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:45:07.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":360000,"price":8.6336,"value":3108096.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.25 to $8.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners I, LP (\"SR One Partners I\"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the SR One Fund I Aggregator securities in which the Reporting Person has no pecuniary interest, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes."}],"balance_after":6486476,"source":{"system":"sec-edgar","filing":"0001209191-22-062227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062227/doc4.xml","form_type":"4"}},{"id":2079930,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:45:07.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":500000,"price":8.2811,"value":4140550.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners I, LP (\"SR One Partners I\"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the SR One Fund I Aggregator securities in which the Reporting Person has no pecuniary interest, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes."}],"balance_after":6126476,"source":{"system":"sec-edgar","filing":"0001209191-22-062227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062227/doc4.xml","form_type":"4"}},{"id":2079977,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":1,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":3,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:37:12.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":40000,"price":8.1358,"value":325432.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.86 to $8.45 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the \"Indirect Reporting Persons\"). The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Indirect Reporting Persons have no pecuniary interest, and this report shall not be deemed an admission that the Indirect Reporting Persons are the beneficial owners of such securities for Section 16 or any other purpose."}],"balance_after":6526476,"source":{"system":"sec-edgar","filing":"0001209191-22-062226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122062226/doc4.xml","form_type":"4"}},{"id":2079976,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":1,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":3,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:37:12.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":360000,"price":8.6336,"value":3108096.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.25 to $8.90 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the \"Indirect Reporting Persons\"). The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Indirect Reporting Persons have no pecuniary interest, and this report shall not be deemed an admission that the Indirect Reporting Persons are the beneficial owners of such securities for Section 16 or any other purpose."}],"balance_after":6486476,"source":{"system":"sec-edgar","filing":"0001209191-22-062226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122062226/doc4.xml","form_type":"4"}},{"id":2079975,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":1,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":3,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:37:12.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":500000,"price":8.2811,"value":4140550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.76 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the \"Indirect Reporting Persons\"). The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Indirect Reporting Persons have no pecuniary interest, and this report shall not be deemed an admission that the Indirect Reporting Persons are the beneficial owners of such securities for Section 16 or any other purpose."}],"balance_after":6126476,"source":{"system":"sec-edgar","filing":"0001209191-22-062226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122062226/doc4.xml","form_type":"4"}},{"id":2089810,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-12T22:22:40.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":15000,"price":7.9617,"value":119425.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased at a range of prices between $7.885 and $8.00.  Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":112024,"source":{"system":"sec-edgar","filing":"0001209191-22-060738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122060738/doc4.xml","form_type":"4"}},{"id":2230095,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":112819,"kind":"person","name":"Xu Stella","position":1,"cik":"0001728741","reported_name":"Xu Stella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:17:23.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037525/doc4.xml","form_type":"4"}},{"id":2230093,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":1,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:16:19.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037524/doc4.xml","form_type":"4"}},{"id":2230094,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":25051,"kind":"person","name":"Schmid John P.","position":1,"cik":"0001478916","reported_name":"Schmid John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:10:11.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037517/doc4.xml","form_type":"4"}},{"id":2230092,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:08:58.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037514/doc4.xml","form_type":"4"}},{"id":2230091,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:07:56.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037511/doc4.xml","form_type":"4"}},{"id":2230090,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:06:56.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037509/doc4.xml","form_type":"4"}},{"id":2230089,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:05:42.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037503/doc4.xml","form_type":"4"}},{"id":2321677,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T23:28:14.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":25000,"price":18.9872,"value":474680.0,"ownership":{"direct":false,"nature":"By Logos Global Master Fund LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Logos Global Management LP (\"LGM\") is the investment adviser of private funds, including Logos Global Master Fund LP (the \"Fund\"). Logos GP LLC (\"Fund GP\") is the general partner of the Fund. The Reporting Person is the Manager of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2797501,"source":{"system":"sec-edgar","filing":"0001209191-22-020638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122020638/doc4.xml","form_type":"4"}},{"id":2321674,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":112819,"kind":"person","name":"Xu Stella","position":1,"cik":"0001728741","reported_name":"Xu Stella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T23:26:18.000Z","date":"2022-03-22","kind":"sale","acquired":false,"shares":1455,"price":18.6292,"value":27105.486,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $18.51 to $18.835, inclusive.  The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C.  Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P.  Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest."}],"balance_after":4129950,"source":{"system":"sec-edgar","filing":"0001209191-22-020637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122020637/doc4.xml","form_type":"4"}},{"id":2321673,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":112819,"kind":"person","name":"Xu Stella","position":1,"cik":"0001728741","reported_name":"Xu Stella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T23:26:18.000Z","date":"2022-03-21","kind":"sale","acquired":false,"shares":24000,"price":19.01,"value":456240.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.00 to $19.30, inclusive.  The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C.  Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P.  Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest."}],"balance_after":4131405,"source":{"system":"sec-edgar","filing":"0001209191-22-020637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122020637/doc4.xml","form_type":"4"}},{"id":2321672,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":112819,"kind":"person","name":"Xu Stella","position":1,"cik":"0001728741","reported_name":"Xu Stella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T23:26:18.000Z","date":"2022-03-18","kind":"sale","acquired":false,"shares":13200,"price":20.34,"value":268488.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $20.70, inclusive.  The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C.  Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P.  Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest."}],"balance_after":4155405,"source":{"system":"sec-edgar","filing":"0001209191-22-020637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122020637/doc4.xml","form_type":"4"}},{"id":2321671,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":112819,"kind":"person","name":"Xu Stella","position":1,"cik":"0001728741","reported_name":"Xu Stella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T23:26:18.000Z","date":"2022-03-18","kind":"sale","acquired":false,"shares":552225,"price":19.04,"value":10514364.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.00 to $19.8726, inclusive.  The Reporting Person undertakes to provide the Issuer, and security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C.  Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P.  Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest."}],"balance_after":4168605,"source":{"system":"sec-edgar","filing":"0001209191-22-020637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122020637/doc4.xml","form_type":"4"}},{"id":2324860,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-18T21:37:03.000Z","date":"2022-03-16","kind":"other","acquired":true,"shares":11806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In-kind distribution from WRG HCD1, LLC of which the reporting person is a member."}],"balance_after":11806,"source":{"system":"sec-edgar","filing":"0001209191-22-020082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122020082/doc4.xml","form_type":"4"}},{"id":2416946,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70334,"kind":"person","name":"Jeffries Sean","position":1,"cik":"0001848377","reported_name":"Jeffries Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:51:46.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":350000,"derivative":{"exercise_price":12.77,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-22-006581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122006581/doc4.xml","form_type":"4"}},{"id":2416945,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:50:52.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":475000,"derivative":{"exercise_price":12.77,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001209191-22-006579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122006579/doc4.xml","form_type":"4"}},{"id":2416944,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:50:01.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":475000,"derivative":{"exercise_price":12.77,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001209191-22-006577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122006577/doc4.xml","form_type":"4"}},{"id":2416943,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70333,"kind":"person","name":"Burgess Julie","position":1,"cik":"0001883722","reported_name":"Burgess Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:49:04.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":50000,"derivative":{"exercise_price":12.77,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-006576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122006576/doc4.xml","form_type":"4"}},{"id":2552253,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70333,"kind":"person","name":"Burgess Julie","position":1,"cik":"0001883722","reported_name":"Burgess Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-04T20:53:44.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest one year after September 13, 2021 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":135000,"derivative":{"exercise_price":14.99,"expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001209191-21-059038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121059038/doc4.xml","form_type":"4"}},{"id":2581845,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":76515,"kind":"person","name":"William Arsani","position":1,"cik":"0001848372","reported_name":"William Arsani","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-02T21:06:13.000Z","date":"2021-08-31","kind":"purchase","acquired":true,"shares":40000,"price":15.45,"value":618000.0,"ownership":{"direct":false,"nature":"By Logos Global Master Fund LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction was $15.45.  The shares were purchased at a range of prices between $15.00 and $15.69, inclusive.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Logos Global Management LP (\"LGM\") is the investment adviser of private funds, including Logos Global Master Fund LP (the \"Fund\"). Logos GP LLC (\"Fund GP\") is the general partner of the Fund. The Reporting Person is the Manager of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2772501,"source":{"system":"sec-edgar","filing":"0001209191-21-054492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121054492/doc4.xml","form_type":"4"}},{"id":2666470,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":78563,"kind":"person","name":"Prasad Deepa","position":1,"cik":"0001867165","reported_name":"Prasad Deepa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T21:21:59.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over a three year period following June 15, 2021 (the \"Grant Date\") such that the option is fully vested on the third anniversary of the Grant Date."}],"balance_after":30000,"derivative":{"exercise_price":27.04,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-040998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121040998/doc4.xml","form_type":"4"}},{"id":2666469,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T21:17:58.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over a three year period following June 15, 2021 (the \"Grant Date\") such that the option is fully vested on the third anniversary of the Grant Date."}],"balance_after":30000,"derivative":{"exercise_price":27.04,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-040988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121040988/doc4.xml","form_type":"4"}},{"id":2764504,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":70334,"kind":"person","name":"Jeffries Sean","position":1,"cik":"0001848377","reported_name":"Jeffries Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-01T22:35:25.000Z","date":"2021-03-30","kind":"purchase","acquired":true,"shares":3050,"price":20,"value":61000.0,"ownership":{"direct":false,"nature":"By domestic partner"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased in the Issuer's initial public offering."}],"balance_after":3050,"source":{"system":"sec-edgar","filing":"0001209191-21-024248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024248/doc4.xml","form_type":"4"}},{"id":2764503,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":140693,"kind":"organization","name":"Quan Venture Fund II, L.P.","position":1,"cik":"0001750370","reported_name":"Quan Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-04-01T22:25:31.000Z","date":"2021-03-30","kind":"exercise","acquired":false,"shares":458016,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":280991},"source":{"system":"sec-edgar","filing":"0001209191-21-024242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024242/doc4.xml","form_type":"4"}},{"id":2764502,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":140693,"kind":"organization","name":"Quan Venture Fund II, L.P.","position":1,"cik":"0001750370","reported_name":"Quan Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-01T22:25:31.000Z","date":"2021-03-30","kind":"exercise","acquired":false,"shares":7236938,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4439839},"source":{"system":"sec-edgar","filing":"0001209191-21-024242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024242/doc4.xml","form_type":"4"}},{"id":2764501,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":140693,"kind":"organization","name":"Quan Venture Fund II, L.P.","position":1,"cik":"0001750370","reported_name":"Quan Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-01T22:25:31.000Z","date":"2021-03-30","kind":"exercise","acquired":true,"shares":280991,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."}],"balance_after":4720830,"source":{"system":"sec-edgar","filing":"0001209191-21-024242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024242/doc4.xml","form_type":"4"}}],"next_cursor":"2021-04-01T22:25:31.000000Z,2764501"}